share_log

China's Medical Products Authority Approves Novo Nordisk's Type-2 Diabetes Treatment To Enter Chinese Market

Benzinga ·  Jun 24 20:53
China's Medical Products Authority Approves Novo Nordisk's Type-2 Diabetes Treatment To Enter Chinese Market
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment